Access to innovative cancer medicines in a middle-income country - the case of Mexico

BACKGROUND: Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin American countries, Mexico has an essential cancer medicines list that includes innov...

Full description

Saved in:
Bibliographic Details
Published in:J Pharm Policy Pract
Main Authors: Moye-Holz, Daniela, Soria Saucedo, Rene, van Dijk, Jitse P, Reijneveld, Sijmen A, Hogerzeil, Hans V
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199792/
https://ncbi.nlm.nih.gov/pubmed/30386627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-018-0153-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items